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sorting experiments indicate t hat a small , but significant, frac-
t ion of unlabeled cells re mains in S phase during epidermal 
regeneration, and hence may not be immediately triggered into 
a more rapid cell cycle progression. 
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Although receptor-specific refractoriness has been 
suggested to be one of the regulatory mechanisms of 
epidermal adenylate cyclase systems, its physiologic sig-
nificance has been a subject of controversy because of 
the r equirement of unusually high concentrations of 
agonis ts to induce refractoriness. In order to dete rmine 
whether the epidermal adenylate cyclase system is reg-
ulated through a refractoriness mechanism by subopti-
mal concentrations of receptor agonists, this study was 
undertaken using pig skin epidermal adenylate cyclase 
systems. 
Pretreatment of pig skin with 0.1-1 J.LM epinephrine 
in vitro resulted in the reduction of the maximal epi-
Manuscript received December 28, 1982; accepted for publication 
July 26, 1983. 
Supported in part by grants 56770501 and 57770677 from t he Min -
istry of Education, J apan, and a grant from t he Lydia Oleary Founda-
t ion, J apan. 
Reprint requests to: Hajime lizuka, M.D., Depa rtment of Dermatol-
ogy, Asahikawa Medical College, 3-11 Nishikagura, Asahikawa 078-11, 
J apan. 
nephrine r esponse (epinephrine-induced cyclic AMP ac-
cumulations) to various degr ees w ithout a lterat ions in 
either low or high K,. cyclic AMP phosphodiester ase 
activities. Repeated pretreatments w er e show n to be 
more effective in inducing r efractoriness than a single 
pretreatment. Appa rently there was no change in t he 
K ,. value for epinephrine , sugges ting tha t the decr ease 
in epinephrine response represents a r eduction in th e 
number but not in the a ffinity of functional be ta -adre -
nergic adenylate cyclase r eceptor sites. This r efracto-
riness by low concentrations of ca techolamine pretreat-
ment w as specific to the beta-adrenergic system , since 
ther e was no reduction in histamine response after the 
epinephrine pretreatment. 
These results indicate that the epidermal beta-adre-
nergic adenylate cycla se system is r egulated by much 
lower concentrations of ca techolamine than wer e pre-
viously described. It was suggested t hat physiologic fluc-
tua tions of plasma ca techolamine levels might have a 
profound effect on epidermal beta-adre ner gic a denylate 
cyclase responsiveness, r esulting in the a lteration of the 
minima l catecholamine level r equired for the successive 
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activation of cyclic AMP-dependent protein kinase, 
which is the predominant target of cyclic AMP in epi-
dermis. 
Prolonged or repeated treatments with drugs or hormones 
can result in tolerance to t heir biologic effects. This phenome-
non has been observed in several t issues and has been named 
desensitization, tachyphylaxis, refractoriness, etc . [ 1- 3]. The 
epidermal adenylate cyclase system has been known to be 
regulated by t his mechanism [4- 6]. Subsequen t to exposure of 
intact epidermal t issue to epinephrine, a reduced capacity to 
accumulate cycl ic AMP is expressed upon addition of epineph-
rine. This loss of responsiveness is specific to the agonist used, 
for example, epidermal tissue made unresponsive to epineph-
rine retained its sensit ivi ty to histamine and vice versa [4]. 
Although this receptor-spec ific refractoriness has been assumed 
to be a physiologically signi ficant regu latory mechanism of the 
epidermal adenylate cyc lase system, previous studies were car-
ried out using unphysiologically high concentrations of agonists 
[4,5]. 
Using the pig sk in slice system, we have investigated the 
regulatory mechanism of epidermal adenylate cyclase system 
in our laboratory [7,8]. During the course of the study, we 
noticed that responsiveness of an epidermal slice to each ago-
nist varied from t issue to tissue obta ined on different occasions. 
Even the responsiveness of skin from the same pig differed if 
the skin slice was taken on a different occasion. These findings 
suggested to us that each receptor adenylate cyclase respon-
siveness might a lready be determined in vivo by physiologic 
fluctuations of each ago nist concentration, i. e., wi t h much lower 
concentrations than were previously described. 
The present study was undertaken to determine whether 
epidermal ade nylate cyclase system responsiveness might be 
influenced by relatively low concent rations of agonists. Among 
four independent receptor adenylate cyclase systems in epider-
mis [9], t he epinephrine adenylate cyclase system was chosen 
since it is well known thE~t plasma catecholamine levels fluc-
tuate because of many physical and emotional stimuli, which 
include exercise, emot ional stimuli , cold stress, etc . (10- 12]. 
MATERIALS AND METHODS 
Domestic pigs weighing about 10- 15 kg were anesthesized with 
Nembuta l (Dainippon, Osaka, J apan) administered i.p. (dose 30 mg/ 
kg) as previously described [5]. Fifteen minutes after the a nesthesia, 
skin slices were ta ken from the bac ks of t he pigs wit h a Castroviejo 
keratome (Storz Instrument Co., St. Louis, Missouri). Keratome shims 
were selected to give a n average t hickness of 0.2 mm and the skin slices 
t hus obtained were histologically checked a nd were confirmed to be 
predominantly epidermis (around 80%). The skin slice was cut into 5 
X 5 mm squares, washed 3 t imes in RPMI1640 medium, floated keratin 
layer up in the same medium , a nd preincubated for 20- 30 min at 37oC 
to standardize t he cyclic AMP level [13]. Skin squares were then t reated 
with various concentrations of epinephrine in the same medium at 
37°C in an atmosphere of 5% C02 in a ir for up to 2 h. After an 
appropriate time, the skin squa res were transferred to a new RPM! 
1640 medium at 37oC a nd treated with 50 JiM epinephrine or 1 mM 
histamine for 5 min. These concentra t ions were chosen to obta in 
max imal responses for cyclic AMP accumulat ions (4]. After the incu-
bation , skin squa res were quickly frozen between two plates of Dry Ice. 
The cycl ic AMP content in t hese skin squa res was measured by 
radioimmunoassay using a Yamasa cyclic AMP assay kit (Yamasa 
Shoyu Co. Tokyo, J apan) after partial purification by t he method of 
Yoshikawa eta! [13]. The cyclic AMP phosphodiesterase activities in 
t hese skin squares were measured by the method of Scott and Solomon 
[14] with minor modifications as described by Adachi et al [15]. The 
substrate cyclic AMP levels were 102 JiM for high K"' and 0.75 JiM for 
low K'" enzyme assays. Protein concent ration was measured by the 
method of Lowry et al [16] . 
Chemicals a nd drugs were all freshly prepared before each experi -
ment and the pH of t he medium was adjusted to 7. The statistical 
significance was determined by Student's t-test. 
RPM! 1640 medium was purchased from Gibco (Grand Island, New 
York). Epinephrine was the product of Daiich i Pharmaceutical Co. 
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(To kyo, Japan). [3H]Adenosine-3' ,5' -cyclic phosphate (sp act 34.5 Ci/ 
mmol) was obtained from New England Nuclear (Boston, Massachu -
setts) . All other chemicals were purchased from Sigma Chemical Co. 
(St. Louis, Missouri) . 
RESULTS 
Fig 1 shows the effect of ep inephrine pretreatment on the 
subsequent epinephrine- induced cyclic AMP accumulations in 
the skin. When pig skin squares were treated with 50 .uM 
epinephrine (A in Fig 1), there was a marked accumulation of 
cyclic AMP after 5-min incubation , which was followed by a 
decrease in cyc lic AMP level despite t he continuous presence 
of epinephrine. After 60-min incubation, skin squares pre-
treated with 50 J.LM epinephrine did not respond to epinephrine, 
resulting in minimal increase in cyclic AMP level. On the other 
hand, skin squares that were not t reated with epinephrine 
responded to 50 J.LM epinephrine, resul t ing in marked cyclic 
AMP accumulations (C in Fig 1) . There was no difference in 
epinephrine-induced cyclic AMP accumulations after 60-min 
incubation when compared with the initial response of the skin 
without 60-min incubation (compare A (maximal response) 
with C in Fig 1) . 
The effect of suboptimal concentrations of epinephrine pre-
treatment is shown (B in Fig 1) . Pig skin squares were treated 
with 0.1 J.LM epinephrine for 60 min and were then incubated 
with 50 J.LM epinephrine. The treatment with 0.1 J.LM epinephrine 
had a minimal effect on t he cyclic AMP levels of the skin. 
However, after pretreatment with 0.1 J.LM epinephrine, skin 
squares responded significantly less than the skin withou t 
epinephrine pret reatment (p < 0.01) (compare Band C in Fig 
1). The response of skin pretreated with 0.1 J.LM epinephrine 
was also significantly less than that of skin without 60-min 
incubation ( p < 0.01) (compare A and B in Fig 1) . There was 
no difference in the time course of epinephrine response after 
pretreatment with 0.1 J.LM epinephrine, and the maximal effect 
was observed at 5-min incubation time (data not shown) . 
In Fig 2 concentration effects of epinephrine on the cyc lic 
AMP levels of skin wi th and without epinephrine pretreatment 
were compared. Skin squares without epinephrine pretreatment 
responded markedly and accumulated cyclic AMP by the treat-
ment with various concentrations of epinephrine ranging from 
0.1- 30 J.LM. Compatible with the findings in Fig 1, skin squares 
pretreated with 0.1 J.LM epinephrine responded to epinephrine 
significantly less than skin without epinephrine pretreatment. 
In both cases, however, the maximal accumulation of cyclic 
AMP was obtained at concentrations of about 3-10 J.LM and, 
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F IG 1. Effects of epinephrine pretreatment on t he subsequent epi -
neprine- induced cyclic AMP accumulations. After preincubation (see 
Materials and Methods ) pig skin squares were t reated with va rious 
concentrations of epinephrine (A =50 JiM, B = 0.1 JiM, C = 0 JiM) and 
were incubated at 37'C. After 60-min incubation, skin squares were 
transferred to a new RPMI 1640 medium containing 50 JiM epinephrine 
at 37°C. The cyclic AMP contents of skin squares at each point of time 
are indicated. The number of each point is shown in pa rentheses. 
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despite moderate vari ations from experiment to experiment, 
th e appa ren t K , va lues for epinephr ine were a round 1 1-lM in 
both skin groups (K, for con t rol skin , 0.9 ± 0.1 !-lM ; K, for 
refractory skin , 1.0 ± 0.2 !-lM) . 
T able I s hows t he effect of repeated pretreatments of ep i-
nephrine on t he subsequent epinephrine- induced cyclic AMP 
accumulations. P ig kin squa res t reated wi t h va rious concen -
t ration s of ep inephrine repeatedly for 3 t imes resp onded less 
than the control skin in a co nce n t rat ion -dependent manner to 
subsequent epinephrine activations. Thus pretreatment wi t h 
higher co ncent rations of epinephrine resul ted in more marked 
re fracto riness o f skin. Furt hermore, it was hown t hat repeated 
pretreatments were much more effective in inducing refracto-
rin ess; for example, pretreatment wi t h 0.1 1-lM epinephrine (for 
3 t imes) resul ted in essen t ia lly t he complete loss o f epinephrine 
responsive ness, which was not observed by a s ingle pretreat-
men t wit h the same (0.1 !-lM) co ncent ration of epinephrine. 
After epinephrine pretreatment, t here was no di fference in 
hi stamine- induced cyclic AM P accumulations (T able I). 
T a ble II s hows t he comparison of cyclic AMP phosp hodies-
0.01 0.1 10 100 
f.J. M 
FI G 2. Concentration effect. of epinephrine after epinephrine pre-
treatment. After preincubation, skin squares were t reated with and 
wi thout 0.1. f.lM epinephrine for 2 h at 37"C. Skin squares were trans-
ferred to new RPMI 1640 media at 37•C and incubated with va rious 
concentrations of epinephrine plus 5 mM theophylline. Incubations 
were done for 5 min at 37•c and cyclic AMP contents in these skin 
squares were measured as described in Materials and M ethods. Resul ts 
represent three independent experimental series. 0-0-Cont rol; • -• -
0.1 f.lM epinephrine pretreated skin . A rrow indicates 0 value. 
te rase activit ies of skin t reated wit h a nd wit hout 0.1 1-lM ep i-
nephrine. T he re was no di fference in eit her low or h igh K, 
cyclic AMP phosphodiesterase activit ies between t he two skin 
groups. 
DISCUSSION 
P hysio logic co nce nt ration s of plasma catecholam ines (nor-
epinephrine and epineph r ine) a re 2-4 n M, which may be in-
creased to 5-15 n M duri ng stress and exerc ise [10,11]. Alt hough 
epidermal beta-adrenergic adenylate cyclase is activated by 
t hese agoni sts, resul t ing in t he spike like accu mulation of cycl ic 
AMP [17], t he co ncen t rat ion required for the detection of 
activated adenylate cyclase was reported to be much hi gher 
t han t hese p hysiologic concent rations . For example, co ns istent 
wit h t he resul ts by Yoshikawa et a l [17], we could detect only 
a small increase in cycl ic AMP level by 0.1 1-l M ep ineph rine 
t reatment (Fig 2), which was about 7 t imes higher than the 
physiologic range of plasma catecholamine level. Furthermore, 
a lt hough receptor-specific refractoriness of epide rma l adenyl-
ate cyclase has bee n establis hed by Adac hi et a l [4], the con -
cen t ration used for t he induction of refractoriness was a lso 
much higher t han t he physiologic range of ago nist concentra-
t ions. Thus t here have been no data ava ilable suggesting that 
physiologic concen t rations of catecholamine have an effect on 
t he beta-adrenergic adenylate cyclase system in epider mis. 
In t his study, using receptor-specific refractoriness phenom -
ena, we could clea rly demonstrate t hat epidermal beta-adrener-
gic adenylate cyclase responsiveness is regu lated by relatively 
low (near physiologic) co ncent rations of t he beta-ad renergic 
agonist, epinephrine. Alt hough 0.1 1-lM epinep hrine had minimal 
e ffect on t he cyclic AMP levels of the skin by itself, after t he 
pretreatment o f t he skin wi t h t his concen t ration of epinep hr ine 
t here was a s ignificant reduction in beta-adren ergic responsive-
ness (B in Fig 1 and Fig 2). Repeated pretreatments were more 
effective in inducing refractoriness t han a single p retreatment 
TA BL E II. Cyclic AMP phosphodiesterase activities befo re and after 
epinephrine pretreatment 
Cont rol 
Epinephrine 
pretreatment 
Cyclic AMP phosphodiesterase activity 
(pmol/ min/mg protein) 
low J{m 
8.6 ± 0.7 
10.4 ± 1.0 
high I<m 
129.7 ± 10.5 
142.7 ± 16.5 
After preincubation, pig skin squares were t reated with and without 
0.1 1-lM epinephrine for 60 min at 37· c . Skin homogenates were prepared 
and phosphodiesterase activities were measured at 0.75 f.lM and 102 f.lM 
for low and high K,. enzyme respectively. Data are expressed as pmol/ 
min/ mg protein (n = 4). 
TABLE I. Effect of repeated pretreatment of epinephrine 
No addi tion 
Epinephrine 
Histamine 
Control 
1.2 ± 0.1 
13.6 ± 2.6 
107.5 ± 9.4 
O.Oli' M 
(3 times) 
1.1 ± 0.1 
11.1 ± 0.4 
N.D.' 
O. I I' M (3 times) 
1.1 ± 0.1 
3.1 ± 0.2" 
152.3 ± 20.9 
Epinephrine pretrea tment 
] 11M O. I IIM 50 I'M 
(3 times) (once) (once) 
1.0 ± 0. 1 1.0 ± 0. 1 1.0 ± 0.1 
1.2 ± 0. 1" 7.7 ± 0.5" 2.1±0.1" 
N.D. N.D. 117.0±16.6 
Afte r preincubation, pig skin squares were treated with various (0, 0.01 f.lM , 0.1 /lM, 50 f.lM ) concentrations of epinephrine at 37•c. Skin squares 
treated wi th 0.01/lM, 0.1!lM , and 1 f.lM epinephrine for 3 t imes were t ransferred twice at 40-min and 80-min incubation time to new RPMJ 1640 
media containing 0.01 !lM, 0.1 f.lM , and 1 f.lM epinephrine, respectively. Cont rol skin squares and skin squares t reated with 1 f.lM and 50 f.l M 
epinephrine once were transferred at 40-min and 80-min incubation t ime to a new RPM! 1640 medium without the addi tion of epinephri ne. 
After 120-min incubation, these 6 groups of kin squares were t ransferred to new RPMI 1640 media at 37 ' C and were then t reated either with 
50 f.lM epinephrine or 1 mM histamine. Incubations for cyclic AMP accumulations were done fo r 5 mi n at 37 ' C without the addition of 
phosphodiesterase inhibitors. Data are expressed as cyclic AMP pmol/ mg protein (n = 3). 
" p < 0.01 compared wi th cont rol. 
• p < 0.01 compared wi th skin t reated 3 times (0.1 f.lM) . 
c N.D. = not determined. 
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(T able [) . As was reported by Adac hi et a l [ 4], the refractoriness 
was receptor-specific (T a ble I) and no cha nge in phosphodies-
terase activit ies was observed by subopt ima l concen t rations of 
agonist t reatmen t (T a ble II ). Furt hermo re, t he appa ren t K ,., for 
epinephrine for beta-adrenergic adenylate cyclase activat ion 
seemed to be unc ha nged afte r t he pa rt ia l desensit ization proc-
ess, suggest ing t hat t he decrease in epinephrine response rep-
resents a reduction in t he number but not t he a ffini ty of t he 
functional beta-adrene rgic adenylate cyclase system in epider -
mis. 
T here a re nume rous reports co nce rning t he mec ha nism of 
dese nsit ization of t he adenylate cyclase system, which is a 
membra ne-boun d e nzyme comp lex composed o f at least 3 dis-
t inct subuni ts: recep tor subunit, cata lytic subuni t, a nd gua nine 
nucleotide bindin g s ite [18]. T he act ivation of the enzyme 
(cata lytic subu n it) requires t he functiona l coupling of t hese 
subu ni ts, a nd it is assumed t hat d urin g t he desensit ization 
process, t he uncoupling of t he receptor and othe r subunits a nd/ 
or the reduction in t he a bsolute number of receptor subunits 
occur [2,3,19,20]. S ince we did not directly measure beta-
adrenergic binding sites before a nd a fte r t he desensitization 
process, no data a re ava ila ble as to whi ch is t he predomina n t 
mec ha nism of epiderm a l ade nylate cyclase re frac toriness at 
prese nt. 
Desp ite the fi nding which suggests t hat act ivation and de-
se ns it ization of ade nylate cyclase might be a sepa ra ble process 
in certai n expe rimen ta l condi t io ns [2,21], it is genera lly ac -
cepted t hat receptor-specific dese ns itization is associated wit h 
activation of t he adenylate cyclase. ystem physiologica lly. It is 
we ll know n th~t o nly ago nists, but not a ntagoni sts, which do 
not lead to coupling a nd activat ion o f adenylate cyclase, pro-
d uce desens it ization [2,22]. T hus it is possibl e that epiderma l 
beta-adrene rgic ade nylate cyc lase was activa ted durin g subop-
t ima l co nce n t ratio ns of epinephrine pretreatment, resulting in 
t he increa ed in t race llul ar level of cyc lic AMP, a lt hough t he 
increase might be too s ma ll to be detected . Recen t ly Yoshikawa 
et a! [23] reported t hat cyclic AMP-dependent protein kinase 
in ep iderm is was full y activated by relatively low concent rations 
of epineph r ine, suggesting t hat prote in kinase activation ta kes 
place in respo nse to a relative ly sma ll increase in t he cyclic 
AMP level. Taken together , it is likely t hat t he epiderma l 
adenylate cyclase-cyclic AM P-prote in kin ase system does fun c-
tio n at nea r physiologic ra nge of catecholamine concen t rations. 
In co nclus io n, ou r data clea rly indicate that t he epidermal 
beta-adre nergic adenylate cyclase system is regu lated through 
a refracto riness mec ha ni sm by relatively low co ncentra tions of 
ep inephrine. T hese resul ts a re cons isten t wi t h t hose of other 
cell systems [24,25], where t he phys iologic conce nt rations of 
plas ma catechola mine regu late t he responsiveness o f the beta-
ad rene rgic adenylate cyclase system. T he resul ta nt fluctuatio ns 
of t he maxi ma l capacity to accumul a te cyclic AMP wit hout a n 
a lteration in K"' value for epinephrine, would resul t in t he 
inversely related fluctuations of t he minimal catechola mine 
leve l requ ired for t he successive activation of epiderma l prote in 
kin ase. In othe r wo rds, pa rt ia lly refracto ry s kin would require 
higher concen t rat io ns of catec hola mine for t he activation· of 
protein kin ase. T hus t he epiderm a l ade nylate cyclase-cyclic 
AMP-protein kin ase syste m seems to be under dy namic regu -
latio n t h rough a n adenylate cyc lase re fracto riness mecha ni sm , 
which may be s ignificantly involved in the regulatory mec ha-
ni sms o f cyc lic AM P- mediated processes in epidermis. 
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